G-I-N 2016 Scientific Committee
Christine Laine, MD, MPH, 2016 Scientific Committee Chair
Brian Alper, MD, MSPH, FAAFP
Michael Barry, MD, MACP
Helen Burstin, MD, MPH, FACP
Vivian Coates, MBA
David Goldmann, MD, FACP
Fergus Macbeth, MA, DM, FRCP, FRCR
Joerg Meerpohl, MD
Bernadette Melnyk, PhD, RN, CPNP/PMHNP, FAAN
Mary Nix, MS, MT (ASCP), SBB
Susan Norris, MD, MPH, MS
Monika Nothacker, MD, MPH
Amir Qaseem, MD, PhD, MHA, FACP
Corinna Schaefer, MA
Holger Schünemann, MD, PhD, MSc, FRCP (C), FACP
Craig Umscheid, MD, MSCE, FACP
Dr. Christine Laine is Editor-in-Chief of Annals of Internal Medicine and Senior Vice President of the American College of Physicians. She is board-certified in internal medicine and sees patients and is on the faculty at Jefferson Medical College in Philadelphia.
Dr. Laine received her medical degree from SUNY Stony Brook, and completed residency at The New York Hospital (Cornell University) and fellowship in general internal medicine and clinical epidemiology at Beth Israel Hospital (Harvard University). Dr. Laine’s master of public health degree is from Harvard University.
She holds leadership positions in the International Committee of Medical Journal Editors, the Council of Science Editors, and the World Association of Medical Editors.
Jos Kleijnen, MD, 2016 Scientific Committee Vice Chair
Dr. Jos Kleijnen did both his medical study and his PhD in Maastricht, where he worked for 6 years in the department of Epidemiology pioneering the methods of doing systematic reviews, in those days on topics of food supplements and alternative medicine. He then moved in 1993 to the Academic Medical Center in Amsterdam to work as a clinical epidemiologist with clinicians and health professionals on their various research projects.
In 1994, Jos founded the Dutch Cochrane Centre and became its first director. In 1998 he was tempted to take on the position of professor and director at the Centre for Reviews and Dissemination at the University of York in the UK. He remained in that job until 2005, when he left to start his own company Kleijnen Systematic Reviews Ltd, also based in York, UK. In 2011, while still remaining in York as the main base, he was appointed in a part-time position as professor of systematic reviews in health care at CAPHRI. Jos has been a keen contributor to the Cochrane Collaboration since its inception in 1993, and is also a strong supporter of the Joanna Briggs Institute in Adelaide, Australia, where he holds a position as clinical professor. Finally, Jos also served on the G-I-N Board from 2003-2005.
Dr. Brian S. Alper is the founder of DynaMed and the Vice President of Evidence-Based Medicine Research and Development, Quality and Standards for EBSCO Health, at EBSCO Publishing, Inc. As a medical student Alper realised he could not possibly memorise sufficient medical information to support practice so he began organising what he was learning electronically. Dr. Alper discovered that his organised information was more useful than textbooks or existing resources used during clinical rotations. During a rotation in rural practice in Eastern Tennessee, Alper saw his disease summary notes making real differences in diagnosis and treatment every day. At this point, the notes weren't in a sophisticated system but he realised that health care professionals needed this kind of resource and has been working to serve this need ever since. As a result, Alper created DynaMed (Dynamic Medical Information System), a clinical reference tool to provide the most useful information to health care professionals at the point of care, and he created a systematic way to monitor current literature and continuously update DynaMed based on the best available evidence.
Dr. Alper earned his MD at Hahnemann University, completed residency in family medicine at Penn State University/Good Samaritan Hospital, and a fellowship at the University of Missouri-Columbia. He is a clinical research assistant professor at University of Missouri-Columbia. He has conducted original research and systematic reviews and taught evidence-based medicine to medical students, residents, fellows and faculty. He has presented numerous lectures and workshops at educational programs, hospitals and national and regional professional meetings and has served as the Co-Chair of the Society of Teachers of Family Medicine Group on Evidence-Based Medicine.
In mid-2005, DynaMed became a member of the EBSCO Publishing family. Dr. Alper saw this union as the best way to continue the DynaMed mission of providing the most useful information to health care professionals at the point of care. As part of EBSCO Publishing, DynaMed continues to grow, improve and provide the best available evidence updated daily for the DynaMed Community which now reaches thousands of hospitals and hundreds of thousands of clinicians in more than 125 countries.
Dr. Alper is a Fellow of the American Academy of Family Physicians (AAFP), and is a member of the American College of Physicians (ACP), Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group, Guidelines International Network (G-I-N), Health Level 7 (HL7) Clinical Decision Support Work Group, the Rosalind Franklin University Global Health Advisory Board, and World Association of Medical Editors (WAME).
Dr. Michael Barry became president of the nonprofit Informed Medical Decisions Foundation in 2009. In 2014, the Foundation became a division of Healthwise, another mission-driven nonprofit. Michael remains president of the Foundation and adds the title of Chief Science Officer at Healthwise. Healthwise’s mission is to help people make better health decisions.
He is a past president of the Society for Medical Decision Making (SMDM) and the Society of General Internal Medicine in the United States. Michael has led many prominent research studies including the Patient Outcome Research Team for Prostatic Diseases. Michael continues to practice primary care and serves as medical director of the John D. Stoeckle Center for Primary Care Innovation at MGH. He is also a professor of medicine, part time, at Harvard Medical School and a Master of the American College of Physicians.
Helen Burstin, MD, MPH, FACP is the Chief Scientific Officer of The National Quality Forum, a not-for-profit membership organization that works to catalyze healthcare improvement through quality measurement and reporting. Dr. Burstin is responsible for advancing the science of quality measurement and improvement. She provides scientific oversight for the evaluation, endorsement and selection of quality measures and the transition to electronic performance measurement.
Prior to joining NQF in 2007, Dr. Burstin was the Director of the Center for Primary Care, Prevention, and Clinical Partnerships at the Agency for Healthcare Research and Quality (AHRQ). In her role, she oversaw the development of an extensive research portfolio at the intersection of health information technology and quality of care. Her center also supported the U.S. Preventive Services Task Force and research on primary care and prevention. She led the development of the first National Healthcare Disparities Report. Prior to joining AHRQ in 2000, Dr. Burstin was an Assistant Professor at Harvard Medical School and the Director of Quality Measurement at Brigham and Women’s Hospital. In her role, she developed a hospital-wide electronic Quality Measurement Reporting System. She also served as the Chair of the Medical Staff Executive Committee on Quality Assurance and Risk Management.
Dr. Burstin is a graduate of the State University of New York at Upstate College of Medicine and the Harvard School of Public Health. Dr. Burstin completed a residency in primary care internal medicine at Boston City Hospital. After residency, she completed fellowship training in General Internal Medicine and Health Services Research at Brigham and Women's Hospital and Harvard Medical School. Dr. Burstin is the author of more than 80 articles and book chapters on quality, patient safety, and disparities. She served as chair of the Quality Measures Workgroup of the federal HHS Health IT Policy Committee. She is a Senior Professorial Lecturer in the Department of Health Policy at George Washington University School of Public Health. Dr. Burstin is a Clinical Associate Professor of Medicine at George Washington University where she serves as a preceptor in internal medicine. She was recently awarded the Alpha Omega Alpha Medical Voluntary Attending Award from the George Washington School of Medicine.
Ms. Vivian Coates developed and leads ECRI Institute’s evidence-based medicine & health technology assessment program, including the Evidence-based Practice Center (EPC) and the Health Technology Assessment Information Service (HTAIS) for health plans, hospitals/health systems, and health policymakers. She initiates and fosters relationships with users of comparative effectiveness and health technology assessment information to promote evidence-based approaches for healthcare coverage, purchasing, delivery, and clinical practice guideline development.
Ms. Coates serves as project director on ECRI’s contract to create, maintain and enhance the National Guideline Clearinghouse and the National Quality Measures Clearinghouse, sponsored by the Agency for Healthcare Research and Quality (AHRQ). The clearinghouses are public resources for information on specific evidence-based clinical practice guidelines and quality measures.Ms. Coates is also responsible for the ECRI contract to create the nation’s first Healthcare Horizon Scanning System for AHRQ, monitoring thousands of new drugs, devices, biologics and procedures across 14 different priority areas. The AHRQ Healthcare Horizon Scanning System focuses on emerging health care technologies and innovations to better inform patient-centered outcomes research investments at AHRQ through the Effective Health Care Program.
As a member of ECRI’s Executive Staff, Ms. Coates also has broad management responsibilities that include the recruitment and oversight of personnel resources as well as the acquisition of material resources to support ECRI's mission to improve the safety, efficacy and cost effectiveness of healthcare.
Dr. David R. Goldmann is Vice President and Chief Medical Quality Assurance Officer in the Clinical Solutions division at Elsevier. As director of the Elsevier’s Evidence-Based Medicine Center, he leads an initiative to generate rapid systematic reviews for integration into the company’s print and electronic content. In addition, he and his colleagues in the Centre provide education and training in evidence-based medicine, offer consultation to Elsevier content developers and manage a quality assurance program.
Dr. Goldmann formerly served as Editor-in-Chief of First Consult, an electronic point-of-care clinical tool and part of Clinical Key, Elsevier’s extensive medical knowledge resource designed to provide physicians with rapid access to evidence-based answers to clinical questions.
Dr. Goldmann is an Emeritus Associate Professor of Medicine in the Perelman School of Medicine at the University of Pennsylvania and a member of the Division of General Internal Medicine in the Department of Medicine. Having practiced internal medicine at Penn for many years and participated in various clinical and teaching activities, he is a now a member of Penn’s Center for Evidence-Based Practice, which develops systematic reviews and guidelines used by various stakeholders within the University of Pennsylvania Health System.
Dr. Goldmann has an extensive background in medical editing and publishing. At the American College of Physicians, he served as Editor-in-Chief of the Physicians’ Information and Education Resource (PIER), another electronic, evidence-based, point-of-care medical decision support tool.
He has held various editorial positions at Annals of Internal Medicine where he initiated the Medical Writings section of the journal and developed a format for structured book reviews. He also served as editorial consultant to the book program at the ACP and has edited several patient education books.
Dr. Goldmann came to Philadelphia for his residency in internal medicine at the University of Pennsylvania in 1972. After residency and a fellowship in endocrinology and metabolic disease at Penn, he joined the Department of Medicine. He directed the medical consultation service and edited one of the first textbooks in consultative medicine.
He received a Bachelor of Arts degree from Harvard University, a medical degree from Harvard Medical School and a Master of Arts degree from the University of Sussex in England. He is a Fellow of the American College of Physicians.
Dr. Fergus Macbeth recently retired from active clinical work after working as a consultant oncologist in Glasgow and Cardiff. He has also worked for the National Institute for Health and Care Excellence (NICE) for almost 10 years, first as Director of the National Collaborating Centre for Cancer, developing cancer guidelines for NICE and latterly, until his retirement, as Director for the Centre for Clinical Practice, responsible for NICE’s wider clinical guidelines and quality standards programmes. He still works part time as Mentor to NICE Fellows and Scholars and is currently chairing the NICE guideline on melanoma.
He has a long standing clinical and research interest in lung cancer, leading and participating in important clinical trials. He has been Coordinating Editor of the Cochrane Lung Cancer Review Group for 5 years and is currently Associate Director of the Wales Cancer Trials Unit, Cardiff and Honorary Professor at Cardiff University. He teaches for the UK Cochrane Centre and the Collaboration for Evidence Based Healthcare in Africa.
Dr. Okwen Patrick Mbah is a Cameroonian medical doctor and health economist with an interest in improving global health outcomes and does public health research, systematic reviews with both Cochrane and Campbell Collaborations.
He currently works at the North West Regional Fund for Health Promotion. Affiliated to the Catholic University of Cameroon (CATUC) department of Health Economics and the Centre for the Development of Best Practices in Health (CDBPS-H), Patrick also works as a health consultant to several international development agencies and governments. Within G-I-N Patrick is the lead of the African G-I-N community.
Dr. Joerg Meerpohl is a board-qualified pediatrician and pediatric hematologist and oncologist. He has been working as a researcher at the German Cochrane Centre since 2007 and was appointed deputy director in 2011 and co-director in 2015. His main research interests include systematic review methodology, transparency in research and related dissemination bias as well as reporting quality. Since 2015, Joerg is a member of the Cochrane Steering Group.
For many years Joerg has been an active member of the GRADE working group, and has run many GRADE workshops at national and international organisations. Joerg worked as GRADE methodology advisor with several WHO panels, the European Stroke Organisation and the Robert Koch Institute in Germany amongst others. In 2013 he founded the GRADE centre in Freiburg, Germany and is a member of the GRADE guidance committee.
Dr. Bernadette Mazurek Melnyk is recognised nationally and globally for both her research-based and innovative approaches to a wide range of health care challenges. She serves as Associate Vice President for Health Promotion, University Chief Wellness Officer, and Professor and Dean of the College of Nursing at The Ohio State University. Also a professor of pediatrics and psychiatry at Ohio State’s College of Medicine, Dr. Melnyk’s expertise spans evidence-based practice, intervention research, child and adolescent mental health, and health and wellness. In addition, she is editor of the journal Worldviews on Evidence-based Nursing, which under her leadership has risen in impact factor ranking to #3 of more than 100 nursing journals.
In 2013, she became one of the few nurses elected to the Institute of Medicine – now the National Academy of Medicine whose members counsel government and private sector leaders to help them make informed health decisions. Dr. Melnyk served a four year term on the 16-member United States Preventive Services Task Force, an independent group of national experts working to improve the health of all Americans by making evidence-based recommendations about clinical preventive services. She also founded and serves as first president for the National Consortium for Building Healthy Academic Communities, a collaboration of universities across the U.S. dedicated to the improvement of population health and well-being in institutions of higher learning.
Dr. Melnyk has received numerous national and international awards, including: the Jessie Scott Award from the American Nurses Association, recognising her work to improve health care quality through the integration of research, education and practice; the NIH/National Institute of Nursing Research’s inaugural Director’s Lectureship award, the National Organisation of Nurse Practitioners’ Lifetime Achievement Award, and induction into Sigma Theta Tau International’s Research Hall of Fame.
Dr. Melnyk earned her Bachelor of Science in Nursing degree from West Virginia University, her Master of Science degree with a specialisation in nursing care of children and pediatric nurse practitioner from the University of Pittsburgh, and her PhD in clinical research from the University of Rochester – where she also completed her post-master’s certificate as a psychiatric mental health nurse practitioner. She is also an elected fellow of the American Academy of Nursing, the National Academies of Practice, and the American Association of Nurse Practitioners. Her record of scholarship includes over 19 million dollars of sponsored funding from federal agencies as PI and 285 publications, including four books.
Ms. Mary Nix has more than 30 years of experience in clinical and research settings. Clinically, she managed blood banking/transfusion medicine laboratories. She transitioned to health services research, applying the analytic skills used for success in clinical pathology to systematic evidence review and evidence-based clinical practice guideline abstraction.
Ms. Nix has certifications in biomedical informatics and project management. She has combined all of this to lead multi-million dollar, national projects for AHRQ’s Center for Evidence and Practice Improvement; these are projects that use data meeting explicit criteria, informatics, technology and design to disseminate evidence-based clinical practice guidelines, health care quality measures, and service and policy innovations, and affect their implementation by practitioners, providers, purchasers, and policy makers.
Dr. Susan Norris has extensive experience with systematic reviews and guideline development related to clinical medicine and public health. For the last three years, she is Secretary of the World Health Organisation (WHO) Guideline Review Committee, where she is responsible for quality assurance of all proposals and final guidelines produced by WHO, for training in guideline development for WHO staff at headquarters and in the regional offices, and for quality improvement of WHO guidelines internationally. She wrote the second edition of the WHO handbook for guideline development (2014) and has led numerous initiatives within WHO to improve guideline quality, including the development of guidance on how to develop evidence-informed, rapid advice guidelines in the context of a public health emergency or humanitarian crisis.
Dr. Norris received her MD and MSc in Experimental Surgery from the University of Alberta, Canada, and MPH from the University of Washington, Seattle, WA, USA. She practiced primary care medicine for 10 years, and was involved in the development of evidence-based care processes at the health care system and practice levels. She has also worked at the US Centers for Disease Control and Prevention, where she led a systematic review team which supported public health guidelines related to diabetes. Dr. Norris is an Associate Professor in the Departments of Family Medicine at Oregon Health and Science University, in Portland, Oregon, USA, where she led research teams conducting systematic reviews for numerous governmental and physician specialty organisations. Her research interests include conflict of interest in guideline development, selective outcome reporting bias, and the use of nonrandomised studies in systematic reviews.
-1994-2000 Trained as a medical specialist for gynecology and obstetrics, PhD 1999,
- 2001-2005 outpatient gynecologist and senior physician at a department of gynecology and
obstetrics in Berlin
- 2001-2003 postgraduate Public Health studies (master of Public Health 2005)
- 2005-2006 project manager and head of section “benchmarking and quality assurance” at the West-German breast center, Düsseldorf
- 2006-2010 scientific associate section “Evidence based medicine and guidelines”, agency for quality in medicine (AZQ)
- 2010-2012 head of section knowledge management/internal quality management (AZQ)
- Since 2012 scientific associate and deputy head AWMF-institute of medical knowledge management
- Lecturer at the Berlin school of public health, Charité
- Speaker of the guidelines section, German Network for Evidence based Medicine
- Chair of the G-I-N Performance Measures Working Group: special interest in guidelines based performance measures and individualisation of guideline recommendations
Dr. Amir Qaseem is responsible for leading the American College of Physicians' evidence-based medicine and clinical practice guidelines program, one of the oldest programs in the United States, including writing of the clinical guidelines, and overseeing the College’s Clinical Guidelines Committee. Dr. Qaseem is also in charge of directing the ACP's physician performance measurement program and is responsible for ACP’s Performance Measurement Committee. He also leads the High Value Care Task Force evaluating and publishing the benefits, harms, and costs of various overused, misused, and underused diagnostic tests and therapeutic interventions. Dr Qaseem’s work includes development and implementation of ACP’s quality improvement and educational programs.
Dr. Qaseem is also involved in several international collaborations to develop joint clinical guidelines and improve quality of care across different countries. Dr. Qaseem has published numerous papers in peer-reviewed journals including clinical practice guidelines, implementation of clinical guidelines, quality improvement, performance measurement, and health policy related issues. Some of the papers authored by Dr. Qaseem are in the top ten most read articles in the Annals of Internal Medicine. Dr. Qaseem has been invited to speak and has presented at several national and international conferences on issues related to health policy, evidence-based medicine, guideline development, guideline and evidence grading, and topics associated with performance measurement and quality of care. Dr Qaseem is also on governance boards and committees of various national and international organisations. Dr. Qaseem was President of the Guidelines International Network (G-I-N) from 2012-13 and was re-elected for 2013-14. He is also a member of G-I-N Board of Trustees.
Ms. Corinna Schaefer trained and graduated in human sciences. She is head of the departments for evidence based medicine/guidelines and patient information/patient involvement at the German Agency for Quality in Medicine (ÄZQ), which she joined in 2006.
Corinna is responsible for the coordination of the German National Disease Management Guidelines Program. She co-chairs the Guidelines International Network Patient and Public Involvement Working Group (G-I-N PUBLIC).
Dr. Schünemann is chair of the Department of Clinical Epidemiology and Biostatistics at McMaster University, widely considered the birthplace of evidence-based medicine. He trained in internal medicine, epidemiology, preventive medicine and public health.
Having contributed to over 400 peer-reviewed publications (across a broad area of health care questions) he is co-chair of the GRADE working group, co-director of the World Health Organisation (WHO) collaborating center for evidence informed policy-making, a member of the Board of Trustees of the Guideline International Network, the Cochrane Collaboration Steering Group, and several other committees. He led or participated in numerous high profile guideline panels, including at the WHO, the American College of Physicians, American Thoracic Society, the World Allergy Organisation and he was a key contributor to the revised methods for WHO guideline development in 2006.
For the past 15 years, he has been advisor to ministries of health and other governmental organisations for their guideline programs. Recently, he has focused on practical application of his work by researchers and clinicians through contributions to the guideline development tool (www.gradepro.org), the guideline checklist (cebgrade.mcmaster.ca/guidecheck.html) and GRADE evidence to decision frameworks (www.decide-collaboration.eu). Maintaining an active clinical practice fulfills his passion for patient care and ensures his research is people-oriented. In his personal life, he has planned to ride the course of a Tour de France, trains vigorously and succeeded partially.
Dr. Britta Tendal is a senior advisor at the division for Hospital Services & Emergency Management at the Danish Health Authority. She has a background in systematic review methodology research and holds a Master of Science in Public Health and a PhD in Health Sciences from the University of Copenhagen.
Britta is the lead methodologist on the Danish National Clinical Guideline Program and has been involved in the development of more than 30 guidelines. She is a steering group member of Guidelines International Network Nordic (G-I-N Nordic), a member of GRADE working group and a member of Cochrane Methods Bias group.
Craig A. Umscheid, MD, MSCE is an Associate Professor of Medicine and Epidemiology at the University of Pennsylvania Perelman School of Medicine, Vice Chair for Quality and Safety in the Department of Medicine, a practicing hospitalist, and Director of the Penn Medicine Center for Evidence-based Practice (CEP), an evidence-based practice center funded by Penn to support patient care quality, safety, and value through evidence-based practice. He is also Medical Director of Clinical Decision Support at Penn, and a Senior Fellow in the Institute for Biomedical Informatics and the Leonard Davis Institute of Health Economics. Dr. Umscheid directs the medical student Evidence-based Medicine education, the Critical Appraisal certificate course, and the graduate student Systematic Reviews course. Outside of Penn, he collaborates with organisations including the Centers for Disease Control and Prevention (CDC) to assist with guideline development, and serves as the Senior Associate Director of the ECRI Institute - Penn Medicine Agency for Healthcare Research and Quality (AHRQ) Evidence-based Practice Center (EPC). He is an invited member of the PCORI Advisory Panel on Improving Healthcare Systems and the AHRQ EPC Methods Steering Committee, a past-member of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), a former Deputy Editor of the Journal of General Internal Medicine, and former Chair of the Society of General Internal Medicine's Evidence-based Medicine Task Force. Dr. Umscheid received his undergraduate degree from Cornell, his medical degree from Georgetown, and a Masters of Science in Clinical Epidemiology from Penn. His post graduate training includes a Residency in Internal Medicine at the University of Chicago.
Dr. Jutta von Dincklage is the Head of Cancer Council Australia’s Clinical Guidelines Network. She has been leading the transition from printed to wiki-based guidelines at Cancer Council Australia over the past five years, including improving uptake and impact on clinical practice of the guidelines by piloting the implementation of online education modules. She has presented and been involved in several publications on the topic and is piloting and collaborating on strategies for living guidelines.
Jutta is a Steering Group member of the G-I-N ANZ Regional Community Group and a member of the GIN 2016 Scientific Program Committee. Prior to joining Cancer Council Australia, Jutta was involved in medical education and coordinated the piloting of the WHO Patient Safety Curriculum Guide for Medical Schools in Sydney.
The G-I-N 2016 Scientific Committee is honored to announce the following list of international speakers.
Professor Mark Baker is the Director of the Centre for Clinical Practice at NICE where he is responsible for the Clinical Guidelines programme and advice on the use of medicines. He joined the staff of NICE in 2009 as Consultant Clinical Adviser to the Internal Guidelines Team and took up his current Director post in April 2012.
Mark qualified in Medicine in 1973 and has postgraduate qualifications in general medicine and public health medicine.
In a wide ranging career in the NHS, he has held the Director or Chief Executive posts at every level of the service. For much of the last twenty years he has been extensively involved in the development of NICE cancer guidance including the Cancer Service Guidance programme, as chair of the guideline development groups on prostate cancer and lung cancer and in his current post. He has also held regional and national leadership positions in cancer services development.
In his academic career, he has also held professorial appointments at the Universities of Bradford, Leeds and York.
He is a Fellow of the Royal College of Physicians and, formerly, a Fitness to Practice Panellist for the General Medical Council.
Professor Baker is presenting in Plenary Panel 3 - Innovative Efficiencies in Guideline Development, Maintenance, and Adaptation: A Look to the Future, on Thursday, 29 September 2016 at 2:00 pm.
Prof. Dr. med. Anke Bramesfeld, MD, MPH, registered in Psychiatry and Psychotherapy, associated Professor in Public Health and Public Mental Health of Hannover Medical School. As current employed as scientific officer at the Joint Research Centre (JRC) in Ispra, Italy, the European Commission's in-house science service that is developing a voluntary European Quality Assurance Scheme for Breast Cancer Services. 2012-2015 AQUA-Institute for applied quality improvement and research in health care GmbH, Göttingen Germany; at that time commissioned with development and implementation of the mandatory quality assurance programme of the German health care system. Before that, health services and system research with a focus on mental health at Hannover Medical School and Leipzig University. 2009-2010 Seconded National Expert to the European Commission's Directorate General for Health and Consumers, Luxembourg.
Dr. Bramesfeld is presenting in Plenary Panel 1 - Translating Guidelines to Performance Measures in an Era of Accountability on Wednesday, 28 September 2016 at 2:30 pm.
Dr. Kate Goodrich joined the Centers for Medicare and Medicaid Services in September of 2011 where she serves as Director of the Center for Clinical Standards and Quality (CCSQ). This Center is responsible for over 20 quality measurement and value-based purchasing programs, implementation of the new Merit-based Incentive Payment System and the Improving Medicare Post-Acute Care Transformation Act, quality improvement programs in all 50 states, clinical standards and survey and certification of all providers across the nation, and all coverage decisions for treatments and services for CMS. The Center budget exceeds $1.3 billion annually.
Previously, Dr. Goodrich served as the Director of the Quality Measurement and Value-based Incentives Group in CCSQ where she oversaw the implementation of over 20 quality, value-based purchasing and public reporting programs across multiple settings. She also co-lead an HHS-wide group to align quality measures across programs, and more recently has worked with numerous private payers to align measures across the public and private sectors. From 2010 – 2011 she served as a Medical Officer in the office of the Assistant Secretary for Planning and Evaluation (ASPE) at DHHS where she managed a portfolio of work on comparative effectiveness research and quality measurement and improvement.
Dr. Goodrich is a graduate of the Robert Wood Johnson Clinical Scholars Program at Yale University where she received training in health services research and health policy from 2008-2010. From 1998 to 2008, Dr. Goodrich was on faculty at the George Washington University Medical Center (GWUMC) and served as Division Director for Hospital Medicine from 2005-2008 and was chair of the Institutional Review Board from 2004-2008. She went to medical school at Louisiana State University in Shreveport, LA, and completed her internal medicine residency and chief medical resident year at GWUMC. She continues to practice clinical medicine as a hospitalist and Associate Professor of Medicine at GWUMC.
Dr. Goodrich is presenting in Plenary Panel 1 - Translating Guidelines to Performance Measures in an Era of Accountability on Wednesday, 28 September 2016 at 2:30 pm.
Dr. Martin Kohn is Chief Medical Scientist at Sentrian, which creates predictive analytic systems integrating home monitoring with longitudinal health data for patients with complex chronic diseases. The Sentrian system identifies patients that are likely to deteriorate to allow the care providers enough time to intervene to mitigate or prevent the deterioration, reducing avoidable hospitalizations.
Dr. Kohn is a board-certified emergency physician with over 30 years of practice and management experience. He is an alumnus of MIT, Harvard Medical School and NYU. He has been a healthcare executive, educator and congressional health policy advisor. Dr. Kohn is board certified in Clinical Informatics, has published on clinical, technical and management subjects and speaks frequently on the role of “Big Data” in the transformation of healthcare. Previously, he was the Chief Medical Scientist for Care Delivery Systems in IBM Research developing analytic tools for healthcare, including the use of the Watson supercomputer.
Dr. Kohn is presenting in Plenary Panel 2 - Incorporating Alternative Forms of Evidence into Guidelines, on Thursday, 29 September 2016 at 8:30 am.
Dr. Kevin Larsen is a senior Medical Officer at the Centers for Medicare and Medicaid Services. He leads the CMS lean transformation and advises on health IT policy and care transformation. He previously served for 4 years as the Medical Director of Meaningful Use at the Office of the National Coordinator for Health IT, where he lead ONCs work on quality policy, measurement and improvement, including clinical decision support and registries. Prior to working for the federal government he was Chief Medical Informatics Officer and Associate Medical Director at Hennepin County Medical Center in Minneapolis, Minnesota. He is also an Associate Professor of Medicine at the University of Minnesota. His research includes health care financing for people living in poverty, computer systems to support clinical decision making, and health literacy. In Minneapolis he was also the Medical Director for the Center for Urban Health, a hospital, community collaboration to eliminate health disparities.
Dr. Larsen is presenting in Plenary Panel 4 - Leveraging Technology to Promote Guideline Implementation, on Friday, 30 September 2016 at 10:30 am.
Dr. Fergus Macbeth recently retired from active clinical working as an oncologist. He also worked for the National Institute for Health and Care Excellence (NICE) for almost 10 years, first as Director of the National Collaborating Centre for Cancer, developing cancer guidelines for NICE and latterly, until his retirement, as Director for the Centre for Clinical Practice, responsible for NICE’s wider clinical guidelines and quality standards programmes. He served on the Board of GIN from 2011 to 2014. He still works part time as Mentor to NICE Fellows and Scholars and has recently chaired two guideline development groups. He has been Coordinating Editor of the Cochrane Lung Cancer Review Group for 5 years and is also joint Funding Arbiter for Cochrane, assessing issues of conflicts of interest across the organisation. He is currently Associate Director of the Wales Cancer Trials Unit, Cardiff and Honorary Professor at Cardiff University. He teaches for the UK Cochrane Centre and the Collaboration for Evidence Based Healthcare in Africa. He has published widely on lung cancer and on guideline related topics.
Dr. Macbeth is presenting in the Opening Plenary – Individualising Guidance in an Era of Personalised Medicine on Wednesday, 28 September 2016 at 9:00 am.
Dr. Lawrence Mbuagbaw is a public health physician, research methodologist and biostatistician. He works as assistant professor in the Department of Clinical Epidemiology and Biostatistics, McMaster University. His research interests are mother and child health, human immunodeficiency virus (HIV) care, health systems research, mHealth and health research methodology – with a focus on enhancing biostatistics and epidemiological techniques to improve health outcomes using pragmatic knowledge translation designs. He has authored over 80 peer reviewed publication with more that 10 systematic reviews and meta-analyses. He is an editor for the Cochrane Infectious Diseases Group and a member of the G-I-N Africa Steering Committee.
Dr. Mbuagbaw is presenting in Plenary Panel 4 - Leveraging Technology to Promote Guideline Implementation, on Friday, 30 September 2016 at 10:30 am.
Professor Jane Noyes is Professor of Health and Social Services Research and Child Health. She moved to Bangor University in 2005, having previously worked at Manchester, York, Keele and Salford Universities, and the National Heart and Lung Institute at the University of London.
Jane is interested in methodology, including: complex intervention development and evaluation, and qualitative and mixed method systematic review methodology. She is a Convenor of the Cochrane Qualitative and Implementation Methods Group and Co-Chair of the Cochrane Methods Executive. She has been actively involved in developing the methods for qualitative and mixed-method synthesis and incorporation of qualitative evidence in guidelines. Jane is currently working a WHO methodologist on a complex WHO guideline where few trials exist.
Jane also specialises in child health and social care research and cost consequences. Her research interests include acute care, complex care, long-term conditions and self-management, transition to adult services, young adulthood with disability, end of life care, and sibling and family care. She has growing interests in international maternal child health in lower and middle income countries, and reverse innovation. Jane is Editor of the Journal of Advanced Nursing. She is an enthusiastic supporter of leading children’s charities in various high profile roles.
Dr. Noyes is presenting in Plenary Panel 2 - Incorporating Alternative Forms of Evidence into Guidelines, on Thursday, 29 September 2016 at 8:30 am.
Douglas K. Owens, MD, MS, is the Henry J. Kaiser, Jr., Professor at Stanford University, where he is a professor of medicine, and, by courtesy, of health research and policy, and of management science and engineering. He is director of the Center for Health Policy in the Freeman Spogli Institute for International Studies and director of the Center for Primary Care and Outcomes Research (PCOR) in the Department of Medicine. He is a general internist and associate director of the Center for Innovation to Implementation at the Veterans Affairs Palo Alto Health Care System. His research focuses on technology assessment, cost-effectiveness analysis, evidence synthesis, and methods for clinical guideline development. Dr. Owens chaired the Clinical Guidelines Committee of the American College of Physicians. He also served on the United States Preventive Services Task Force (USPSTF), which creates national guidelines on prevention services. Recently, he has helped lead the development of national U.S. guidelines on screening for HIV, hepatitis C, hepatitis B, lung cancer, colorectal cancer, breast cancer, and use of aspirin and statins to prevent cardiovascular disease.
Dr. Owens is presenting in the Opening Plenary – Individualising Guidance in an Era of Personalised Medicine on Wednesday, 28 September 2016 at 9:00 am.
Paul G. Shekelle, MD, MPH, PhD In addition to currently serving as a Staff Physician at the West Los Angeles Veterans Affairs Medical Center, Dr. Shekelle directs the VA Evidence Synthesis Program there. Dr. Shekelle also has served as the Director of the Southern California Evidence-based Practice Center for the RAND Corporation since 1997. He is a Professor of Medicine at the University of California, Los Angeles (UCLA) School of Medicine. He is widely recognized in the field of guidelines, quality measurement, and evidence-based medicine. He is the immediate past-chair of the Clinical Guidelines Committee of the American College of Physicians.
After receiving a B.S. in both Biology and Chemistry at the University of Illinois, Dr. Shekelle earned his MD in 1982 from Duke University. He completed his internship, residency, and fellowship at UCLA, where he also obtained his MPH in 1989 and his PhD in 1993.
Dr. Shekelle is presenting in Plenary Panel 3 - Innovative Efficiencies in Guideline Development, Maintenance, and Adaptation: A Look to the Future, on Thursday, 29 September 2016 at 2:00 pm.
Per Olav Vandvik, MD, PhD, is associate professor at the Department of Health Management and Health Economics, University of Oslo, Norway. He is also researcher at the Norwegian Knowledge Centre for the Health Services in Oslo and acting consultant at the Department of Medicine, Lovisenberg Diaconal Hospital.
Dr.Vandvik spends most of his time heading a team dedicated to develop innovative solutions for providing clinicians and patients with trustworthy evidence summaries, guidelines and decision aids at the point of care (www.magicproject.org). More lately his work includes wide international collaboration to develop a Digital and Trustworthy Evidence Ecosystem. Dr.Vandvik is a G-I-N Board of Trustees member and also a recognized teacher in evidence-based medicine and guideline methodology for clinicians and decision-makers in health care.
Dr. Vandvik is presenting in Plenary Panel 4 - Leveraging Technology to Promote Guideline Implementation, on Friday, 30 September 2016 at 10:30 am.
Lelis Bauza Vernon, BA is chair of the Parent Advisory Council for the Neonatal Intensive Care Unit (NICU) at Baptist Children’s Hospital in Miami, Florida, U.S. Through the Council, she has worked for the past 8 years to create, grow, and coordinate educational and programmatic activities from a parent’s perspective to promote family-centered care in the NICU. She also actively participates and collaborates in specific study groups, including a NIH-funded study by Dr. Jochen Profit, MD, MPH at Stanford University, Division of Neonatal Medicine - Perinatal Systems Research to assess disparities in the quality of care in NICUs, she is currently serving as Faculty member in the Micro-premature Care Team at the Vermont Oxford Network, an exemplary organization that collects and feeds back NICUs clinical data from more than 90% of VLBW babies in the United States, in this role she helps guide quality improvement efforts and extract systematic learning for NICUs around the US. She is also a US Family representative in the Advisory Council for the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) Federation International. In 2016, Lelis joined the American College of Physician’s Public Involvement Program as a public jury member for its Clinical Guidelines Committee.
Lelis’ commitment to advocating the family and patient voice is driven by her experiences as the mother of premature twins and the wife of a spinal cord injury patient. Lelis is originally from Argentina, studied in England, and has lived in Brazil, Venezuela, and the United States.
Ms. Lelis Vernon is presenting in the Opening Plenary – Individualising Guidance in an Era of Personalised Medicine on Wednesday, 28 September 2016 at 9:00 am.
Dr. Diane Watson was the inaugural Chief Executive Officer of the National Health Performance Authority - Australia’s national organisation established to monitor, and report on, the comparable performance of health care organisations and the health system at the local level. This information is available on the MyHospitals and MyHealthyCommunities websites.
In 2015-16 she was co-chair of the Independent Hospital Pricing Authority and Australian Commission for Safety and Quality in Healthcare’s committee to explore the feasibility of implementing best practice pricing nationally, in tandem with quality and safety performance information in order to drive quality improvement.
Prior to her appointment at the Performance Authority, Diane was the inaugural Chief Executive Officer of the NSW Bureau of Health Information. Prior to working in Australia, she held management and senior scientist positions in Canada and the USA. In 2005, Diane was a Harkness Fellow in the International Health Policy Program with the Commonwealth Fund.
Dr. Watson is presenting in Plenary Panel 1 - Translating Guidelines to Performance Measures in an Era of Accountability on Wednesday, 28 September 2016 at 2:30 pm.
Naohito Yamaguchi, MD, PhD, graduated from Keio University School of Medicine, Japan, in 1978, and started his career as researcher in epidemiology and public health. Currently, he is professor and chair of Department of Public Health, Tokyo Women’s Medical University School of Medicine.
Prof. Yamaguchi has been serving as the Director of Minds Guideline Center, Japan, since its foundation in 2002. Minds Guideline Center was established by the Japan Council for Quality Health Care, a non-profit third party organization, with a full financial support by the Ministry of Health, Labor and Welfare, Japan, to promote evidence-based clinical practice in Japan. Minds Guideline Center functions as the clearinghouse of clinical practice guidelines developed in Japan; its website disseminates more than 160 clinical practice guidelines. Minds Guideline Center also has a wide range of guideline-related activities; it supports guideline developers by providing methodological guidance; it also supports hospitals and clinics for efficient guideline implementation; and it supports patients and practitioners for their utilization of clinical practice guidelines in share decision making.
Prof. Yamaguchi is currently serving as the chair of G-I-N Asia, which was founded in 2015.
Prof. Yamaguchi is presenting in Plenary Panel 3 - Innovative Efficiencies in Guideline Development, Maintenance, and Adaptation: A Look to the Future, on Thursday, 29 September 2016 at 2:30 pm.
Teun Zuiderent-Jerak, PhD, is LiU Research Fellow and Senior Lecturer in Science and Technology Studies at the Department of Thematic Studies – Technology and Social Change of Linköping University, Sweden. His research focuses on standardization and quality improvement practices in health care and with a particular focus on medical knowledge. He co-chairs the G-I-N Working Group on Appraising and Including Different Knowledge (AID Knowledge). His publications can be found in the British Medical Journal, BMJ Quality and Safety, BMC Medical Research Methodology, Health Care Analysis, Health Economics, Policy and Law, Health Expectations, Health Policy, Human-Computer Interaction, Science as Culture, Science, Technology, and Human Values, Social Science & Medicine, and Social Studies of Science. His book Situated Intervention; Sociological Experiments in Health Care was published in 2015 by the MIT Press.
Mr. Zuiderent-Jerak is presenting in Plenary Panel 2 - Incorporating Alternative Forms of Evidence into Guidelines, on Thursday, 29 September 2016 at 8:30 am.
The 2016 G-I-N Conference theme “Individualised Guidelines and Clinical Performance Measurement in an Era of Personalised Medicine” addresses many important issues that payers, providers, and policy makers are currently struggling to address in an effort to improve patient care and outcomes. With growing national and international interest in precision medicine, and the recognition of the importance of adapting clinical practice guidelines to meet the needs of disparate populations and complex patients with multimorbidity, the 2016 G-I-N meeting in Philadelphia will be timely, and will make important contributions to the development of high-quality clinical practice guidelines and related clinical performance measures, ultimately facilitating safer, more effective, and more patient-centred healthcare.
The two key social networking events are included in the full conference registration. Additional tickets may be purchased when registering for the conference.
Please note that onsite tickets will be not available.
Date: Tuesday, 27 September 2016
Time: 18:30 – 20:00
3260 South Street, Philadelphia, PA
Join the G-I-N 2016 Local Host Committee as they welcome you to the conference and Philadelphia! The reception being hosted at the University of Pennsylvania Museum of Archaeology and Anthropology — commonly called Penn Museum — is an archaeology and anthropology museum that is part of the University of Pennsylvania.
Gala Networking Event
Date: Thursday, 29 September 2016
Time: 19:00 – 22:30
Location: The National Constitution Center
The National Constitution Center is the selected venue for the annual Gala Networking Event. This location is an essential Historic Philadelphia destination where visitors of all ages and backgrounds can explore the history and relevance of the U.S. Constitution, celebrate their freedoms, and embrace their role in the story of "We the People."
Located on Independence Mall in Historic Philadelphia, the birthplace of American freedom, the National Constitution Center illuminates constitutional ideals and inspires active citizenship through a state-of-the-art museum experience, including hundreds of interactive exhibits, films and rare artifacts; must-see feature exhibitions; the internationally acclaimed, 360-degree theatrical production Freedom Rising; and the iconic Signers’ Hall, where visitors can sign the Constitution alongside 42 life-size, bronze statues of the Founding Fathers. Some of the displays and exhibits will be open the evening of the event.
Schedule at a Glance_8.14.pdf — PDF document, 246 kB (252,653 bytes)
PreConference Course 1_Website.pdf — PDF document, 342 kB (351,088 bytes)
Final Program_Spreads_9.19.pdf — PDF document, 4,744 kB (4,858,271 bytes)
Thank you to all the authors who have contributed to the success of the G-I-N 2016 Conference. Please click here to view the Abstract Book.
GIN_FINAL_PROGRAM_final web_V4.pdf — PDF document, 4,748 kB (4,862,241 bytes)